Previous studies have sought to determine the relationship between cancer and a vegetarian diet. In this study, the researchers examined the impact of various vegetarian and non-vegetarian diets on the risk...
In a recent large observational study, researchers investigated the relationship between varying durations of hormone replacement therapy and the risk of breast cancer.
With the well-documented promotive role of estrogen in breast cancer in mind, investigators aimed to compare breast cancer risk among postmenopausal women with long-term estrogen use vs those who did not...
Researchers prospectively evaluated bone data of more than 200 breast cancer survivors and more than 500 cancer-free women to compare osteopenia and osteoporosis incidence.
Previous research has indicated that hyperlipidemia may be a risk factor for cancer, although the effects of the condition, and of cholesterol-lowering drugs on cancer risk remain uncertain.
The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.
After a review of existing data, the Endocrine Society has released several recommendations and statements regarding the treatment of symptoms associated with estrogen depletion following breast cancer. ...
In a recent study, researchers tested the safety and efficacy of a treatment combination for women with advanced breast cancer who experienced disease progression while receiving endocrine therapy. To see...
